Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited ( (AU:BDX) ) just unveiled an announcement.
BCAL Diagnostics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting its commitment to transparency and accountability in its operations.
More about BCAL Diagnostics Limited
BCAL Diagnostics Limited operates in the healthcare industry, focusing on diagnostic solutions. The company is known for developing innovative diagnostic technologies aimed at improving health outcomes.
Average Trading Volume: 153,667
Technical Sentiment Signal: Sell
Current Market Cap: A$23.42M
For detailed information about BDX stock, go to TipRanks’ Stock Analysis page.